Aclipse Therapeutics focuses on developing differentiated drugs to address diseases with unmet medical needs.
Description
Aclipse Therapeutics is a biopharmaceutical company that focuses on developing differentiated drugs to address diseases with unmet medical needs. Its strategy is reducing clinical development risk by combining a new and druggable understanding of disease pathways with a novel drug molecule that inhibits these pathways, allowing us to build upon existing nonclinical and clinical data while creating a significant patent barrier-to-entry.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Radnor, Pennsylvania, United States, North America